Review decisions
Showing 740 results of 2627 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00963
Product Type: Drug
Control Number: 259440
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-12-10
Decision / Authorization Date: 2022-06-15
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00981
Product Type: Drug
Control Number: 253502
DIN(s): 02527707
Manufacturer: Amylyx Pharmaceuticals Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-06-07
Decision / Authorization Date: 2022-06-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1693591697586
Product Type: Drug
Control Number: 261689
DIN(s): 02538652, 02538660, 02538725, 02538733, 02538741, 02538768, 02538776, 02538784, 02538792, 02538806, 02538814
Manufacturer: Endo Ventures Ltd.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-06-09
Issued / Original Publication Date: 2023-08-31
Decision / Authorization Date: 2023-06-12
Updated Date: 2025-08-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00960
Product Type: Drug
Control Number: 258717
DIN(s): 02527588
Manufacturer: Immunocore Ireland Ltd.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-11-19
Decision / Authorization Date: 2022-06-07
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00959
Product Type: Drug
Control Number: 251277
DIN(s): 02527715
Manufacturer: Kyowa Kirin, Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-03-31
Decision / Authorization Date: 2022-06-02
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00950
Product Type: Drug
Control Number: 261729
DIN(s): 02509210, 02522454
Manufacturer: Pfizer Canada ULC., on behalf of BioNTech
Manufacturing GmbH
Submission Type: Supplement to a New Drug Submission (COVID-19)
Date Filed / Submission Date: 2021-02-23
Decision / Authorization Date: 2022-06-01
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1703192825535
Product Type: Drug
Control Number: 256629
DIN(s): 02541416
Manufacturer: Bristol-Myers Squibb Canada
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-06-01
Issued / Original Publication Date: 2023-12-21
Decision / Authorization Date: 2023-09-13
Updated Date: 2025-02-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00961
Product Type: Drug
Control Number: 253904
DIN(s): 02527618
Manufacturer: Hoffmann-La Roche Ltd.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-06-18
Decision / Authorization Date: 2022-05-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00966
Product Type: Drug
Control Number: 251005
Manufacturer: Biogen Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-03-23
Decision / Authorization Date: 2022-05-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00998
Product Type: Drug
Control Number: 252254
Manufacturer: Bracco Imaging Canada
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-04-30
Decision / Authorization Date: 2022-05-24